Proud to be part of the @Illumina Connected Software team bringing #AI into #NGS labs. Join @ramimehio at #PMWC24 to learn about the advantages of integrating AI in your #Genomics workflows. #GenomicsAI #PMWC24 day 1 9:30am track S1
pmwcintl.com/program/?pmwc-p…
Join August 23rd to learn how Illumina’s Correlation Engine contextualizes private data with curated public data, accelerating your multiomics research.
Register for the webinar here.
shorturl.at/LOPT9 #genomics #drugdiscovery #targetdiscovery #multiomics
Here is a revised copy with shortened link - Last week at #BioIT23, we relaunched @illumina Correlation Engine, an interactive knowledgebase designed to identify correlations between biological entities. Read more #multiomics #biomarkerdiscovery
shorturl.at/fsT01
Mike Lelivelt retweeted
Christian Marshall at @SickKidsNews presenting clinical WES and WGS. Finding accuracy with short reads allowing them to do 30x instead of 40x depth. Dragen and Emedgene
Thank you @BioITWorld for the article on Connected Software and new integrations with Correlation Engine. Interested in more? Join us for lunch at #BioIT23 and hear from @eurofinsviracor and @MycoTechCorp on Day 4 of the #datascience track.
xitter.cf/bioitworld/status/1656…
"Illumina Relaunches Correlation Engine, Banking on Need for ‘Omics Informatics Tools" bio-itworld.com/news/2023/05…
Please join Illumina Global Product Marketing and GenomeWeb on May 11, 10 am PT, for Accelerating Precision Medicine with Low-Cost Whole-Genome Sequencing: An expert panel discussion.
event.on24.com/wcc/r/4174507…
Illumina Connected Analytics - the bioinformatics platform for laboratory operations at @eurofinsviracor
#illuminaconnectedsoftware
.@eurofinsviracor uses Illumina Connected Analytics cloud computing to analyze massive and complex data sets—reducing turnaround time and enabling greater insights. bit.ly/3oVl1Bg
ALT Image of the Eurofins Viracor building.
Great publication about automated case analysis in Emedgene with our parter customers at Baylor.
Congratulations to our Emedgene colleagues, as well as @BaylorGenetics, for this well-deserved recognition. Their research demonstrates the potential of automation to help speed rare disease diagnosis and treatment.
Mike Lelivelt retweeted
Special to see the 1st ever #genomics symposium at our new facility so well attended - 300+ ppl from 60 countries!
Prof. @Tuliodna gave examples of the "holistic collaboration" between scientists all across Africa. @AfricaCDC @RockefellerFdn @WHOAFRO @SUhealthsci @fdesouza – at Cape Town, South Africa
So proud to be invited to the opening of the new Biomedical Research Institute at Stellenbosch University in Cape Town, South Africa. Thank you Tulio de Oliveira for the partnership. Thanks to my fellow colleagues - Ana Carrera Bridget Mogale and Kathryne Reeves #illumina
Privacy ranks up there with accuracy as critical components of genomics impacting human culture.
Our newest privacy certification helps our customers comply with national and international data privacy standards, and better protects sensitive NGS data from potential cyberattacks.illumina.com/company/news-ce…
Illumina Connected Insights brings powerful interpretation and report generation capabilities to our oncology customers, demonstrating our ongoing commitment to driving precision medicine.
Illumina Connected Insights enables our customers to perform interpretation and report generation at scale for somatic oncology and soon, rare disease. Read more about how Connected Insights drives precision medicine at scale. illumina.com/company/news-ce…
Great to see this story about NysnoBio. They are leveraging both Illumina Connected Analytics and our new Cohorts tool to #Parkinson's disease research. #IlluminaConnnectedSoftware
Meet the team at @NysnoBio taking a novel approach to #Parkinson’s disease research. They’re seeking a therapy to replace the Parkin #gene in people who are missing it to arrest the progression of the disease in patients. bit.ly/3xsCkKF
ALT Dr. Johnston, CEO and Co-Founder of NysnoBio, examines cell media.
ALT NysnoBio team members outside their lab in Alachua, Florida posing for a group photo.
ALT Dr. Johnston and Dr. Ron Mandel with a box of microscope slides for pathology samples.
Standing room only at #ASHG22 for Andrew Shaver to discuss Illumina Complete Long Reads
Looking forward to the Illumina Informatics Event on Tuesday at 9 AM next week at #ASHG2022. Hear how Illumina customers such as Patti Connolly from Verici Dx, Eric Venner from All of Us, and Christian Marshall from Sick Kids are using our software.
If you’ll be at ASHG, I’ll be presenting at our informatics event: End-to-End Informatics Solutions Enabling Precision Medicine on Tues. Oct 25th. Be sure to register:
eventregistration.illumina.c…
It went by quickly but today @Alex_Aravanis announced that DRAGEN was the both "the most accurate and comprehensive" secondary analysis platform . The "most accurate" is a bit "old news". The claim of "most comprehensive" is new. #DRAGEN #FullyFeatured
Yet another NGS secondary analysis bake off. Yet another clear and unambiguous recommendation for DRAGEN.
The world is moving beyond Q30 as the metric of quality. Move beyond base calling. It's no longer just about 2x150 @ Q30
biorxiv.org/content/10.1101/…
Mike Lelivelt retweeted
#DRAGEN 4.0 introduces two new exciting pipelines: #SingleCell ATAC-Seq and #SingleCell multiomics. Learn more bit.ly/3SRjVRp
The most comprehensive version of #DRAGEN is now out. With new features and increased efficiency and accuracy, DRAGEN 4.0 helps labs of all sizes uncover the genomic insights that can revolutionize healthcare.
bit.ly/3oxNucC
#genomics #bioinformatics #sequencing